ÂÜÀòÂÒÂ×

A board-certified medical oncologist with a distinguished academic career (Yale, Harvard, Cornell) and 25+ years of pharmaceutical industry experience. He has held Director and Vice President positions at Boehringer Ingelheim, Pharmacia, Ariad and other biopharmaceutical companies before founding his own company, Alopexx Enterprises, LLC. That company successfully licensed its technology to Sanofi for $375 million. Dr. Vlock has had responsibility for numerous clinical development programs including pivotal, multi-center Phase III studies.